A carregar...

HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis

BACKGROUND: Patients with Multiple Sclerosis (PwMS) display altered lipoproteins levels and function, which seem to affect disease risk and progress. Whether disease-modifying therapies affect the lipoprotein profile in PwMS has scarcely been studied. OBJECTIVE: The study aims to assess whether fing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler J Exp Transl Clin
Main Authors: Blumenfeld Kan, S, Staun-Ram, E, Golan, D, Miller, A
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794658/
https://ncbi.nlm.nih.gov/pubmed/31662882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217319882720
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!